What is Envoy Medical's other additional capital?

Envoy Medical (COCH) reported other additional capital of $10M in Q1 2026.

How has Envoy Medical's other additional capital changed year-over-year?

Envoy Medical's other additional capital decreased by 0.0% year-over-year, from $10M to $10M.

What is the long-term trend for Envoy Medical's other additional capital?

Over 2 years (2023 to 2025), Envoy Medical's other additional capital has grown at a 0.0% compound annual growth rate (CAGR), from $10M to $10M.

Envoy Medical COCH Other Additional Capital

Other financials

Income statement

See full

Revenue$39.0K-15.2%

Gross profit-$274.0K-52.2%

Operating income-$6.0M-16.7%

Net income-$4.4M+12.9%

EPS (diluted)-$0.08+72.4%

Balance sheet

See full

Cash & equivalents$25.3M+376%

Total debt$919.0K-2.8%

Total equity$10.2M+142%

Total assets$29.8M+187%

Cash flow

See full

Operating cash flow-$6.1M-62.7%

CapEx$172.0K—

Free cash flow-$5.9M-28.5%

Valuation

See full

Market cap$61M+83.5%

P/S260.7×+111×

Profitability

See full

Gross margin-310.7%+31.6pp

Operating margin-9,881.2%+805pp

Net margin-9,875.6%+771pp

FCF margin-7,626.6%-652pp

Returns & leverage

See full

Return on equity328.7%—

Debt / equity0.1×—

Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept us-gaap:OtherAdditionalCapital.

The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's other additional capital.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Envoy Medical's other additional capital?: Envoy Medical (COCH) reported other additional capital of $10M in Q1 2026.
How has Envoy Medical's other additional capital changed year-over-year?: Envoy Medical's other additional capital decreased by 0.0% year-over-year, from $10M to $10M.
What is the long-term trend for Envoy Medical's other additional capital?: Over 2 years (2023 to 2025), Envoy Medical's other additional capital has grown at a 0.0% compound annual growth rate (CAGR), from $10M to $10M.